Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Western Blot Products
  4. General Western Blot Reagents
  5. 502704881

Abcam Fascaplysin, ATP-competitive CDK4 Inhibitor, Solid, 5 mg

Catalog No. 502704881
Encompass_Preferred
Change view
Click to view available options
Quantity:
5 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
50-270-4881 5 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 50-270-4881 Supplier Abcam Supplier No. AB1461775MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Description

Potent, selective ATP-competitive CDK4 inhibitor with anti-proliferative and pro-apoptotic effects in vitro.

  • Molecular weight: 306.75 g/mol
  • Inhibitor type: Potent, selective ATP-competitive CDK4 inhibitor (IC50 = 350 nM)
  • Key biological effects: Suppresses VEGF expression, inhibits endothelial cell proliferation, and induces apoptosis and cytotoxic autophagy in vitro
  • Form: Solid
  • CAS number: 114719-57-2
  • Storage: Store at -20°C

The product is subject to the following: Abcam Restricted Use Statement

Specifications

Target Molecule CDK4
Content And Storage Store at -20°C.
Form Solid
Shipping Condition Ambient
Formulation 100% 3-aza-13-azoniapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(13),2(10),4,6,8,11,14,16,18-nonaen-20-one chloride
Quantity 5 mg
For Use With (Application) CDK4 inhibition, VEGF suppression, inhibition of endothelial cell proliferation, apoptosis induction, cytotoxic autophagy induction
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.